Investment & M&A transaction comps
Supplements Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged supplements. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 71
- With value data
- 42
- With revenue multiples
- 36
- Transaction years
- 2005–2026
Sortable transaction comps
Supplements transaction table
Rows with reported value
13 / 25
Acquisition EV, USD
USD 32B
Investment EV, USD
-
Median EV / revenue
4.0x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 71 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Zywie Ventures Private Limited (OZiva) Control (51%) | 2023-01-10 | Unilever PLC | Undisclosed | Undisclosed | - | - | - | Confirmed 6 sources | ||
| Chr. Hansen Holding Control | 2022-12-12 | Novozymes | USD 12B | 12,300 | 9.3x | 26.2x | Denmark | Confirmed 1 source | ||
| Hilma Control | 2022-11-17 | Biocodex | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Bucklebury Control | 2022-09-01 | Haleon | Undisclosed Undisclosed | Undisclosed | - | - | United Kingdom | Confirmed 1 source | ||
| The Better Health Company Control | 2022-06-29 | Nestle | Undisclosed Undisclosed | Undisclosed | - | - | New Zealand | Estimated 2 sources | ||
| Clif Bar & Company Control (100%) | 2022-06-20 | Mondelēz International | USD 2.9B Enterprise Value | 2,900 | 3.6x | 24.2x | United States | Confirmed 11 sources | ||
| Youtheory Control (95%) | 2022-06-01 | Jamieson Wellness Inc. | Undisclosed | Undisclosed | 1.8x | 10.0x | North America | Confirmed 1 source | ||
| Orgain Control | 2022-02-02 | Nestlé Health Science | USD 2.0B Estimated Enterprise Value | 2,000 | 1.5x | 22.0x | United States | Confirmed 1 source | ||
| BODYARMOR Control (85%) | 2021-11-01 | The Coca-Cola Company | USD 6.6B Enterprise Value | 6,588 | - | - | United States | Confirmed 2 sources | ||
| Uqora Control | 2021-07-08 | Pharmavite | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Onnit Lab Inc. Control (100%) | 2021-05-28 | Unilever PLC | Undisclosed | Undisclosed | - | - | United States | Confirmed 11 sources | ||
| 2021-04-30 | Nestlé | USD 5.8B Consideration | 5,750 | 3.1x | 16.8x | - | Confirmed 2 sources | |||
| Onnit Labs, Inc. Control (100%) | 2021-04-26 | Unilever | Undisclosed | Undisclosed | - | - | United States | Estimated 1 source | ||
| Grenade Control | 2021-03-22 | Mondelēz International | GBP 200M Consideration | 279 | 4.0x | 40.0x | United Kingdom | Estimated 1 source | ||
| Microbiome Labs Control | 2021-01-06 | Novozymes | USD 125M Consideration | 125 | 3.1x | 6.0x | United States | Confirmed 1 source | ||
| Biogix, Inc. Control | 2020-12-29 | Alliance Pharma plc | USD 110M Enterprise Value | 110 | 5.0x | 15.7x | - | Estimated 3 sources | ||
| Smarty Pants Control (100%) | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 2 sources | ||
| Natrol LLC Control (100%) | 2020-10-26 | New Mountain Capital | USD 550M Consideration | 550 | 3.5x | - | United States | Confirmed 1 source | ||
| Jennewein Biotechnologie GmbH Control (100%) | 2020-09-22 | Chr. Hansen Holding A/S | EUR 310M Enterprise Value | 367 | 6.2x | - | Germany & Global | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| GlaxoSmithKline Bangladesh Limited Control (82%) | 2020-06-30 | Unilever PLC | Undisclosed | Undisclosed | - | - | Bangladesh | Confirmed 5 sources | ||
| PrecisionBiotics Group Limited Control (100%) | 2020-06-25 | Novozymes | DKK 600M Enterprise Value | 90 | 6.0x | - | Cork, Ireland | Estimated 1 source | ||
| Vital Proteins Control | 2020-06-10 | Nestlé Health Science | Undisclosed | Undisclosed | 4.3x | - | - | Confirmed 1 source | ||
| UAS Laboratories LLC Control | 2020-06-09 | Chr. Hansen Holding A/S | USD 530M Enterprise Value | 530 | 6.2x | - | United States | Confirmed 1 source | ||
| Orgain Control | 2019-11-11 | Butterfly Equity | Undisclosed Undisclosed | Undisclosed | 2.8x | 26.3x | United States | Confirmed 1 source |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.